Design and synthesis of novel dihydropyridine alpha-1A antagonists

Design and synthesis of novel dihydropyridine alpha-1A antagonists Design and Synthesis of Novel α_1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia Selective α1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones Long-acting dihydropyridine calcium antagonists. 5. Synthesis and structure-activity relationships for a series of 2-[[(N-substituted-heterocyclyl)ethoxy]methyl]-1,4-dihydropyridine calcium antagonists Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives Long acting dihydropyridine calcium antagonists. 2. 2-[2-aminoheterocycloethoxy]methyl derivatives α₁-Adrenoceptor Antagonists. 6. Structural Optimization of Pyridazinone−Arylpiperazines. Study of the Influence on Affinity and Selectivity of Cyclic Substituents at the Pyridazinone Ring and Alkoxy Groups at the Arylpiperazine Moiety In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α_1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia New 1,4-dihydropyridine derivatives combining calcium antagonism and .alpha.-adrenolytic properties Studies on quinazolines. 5. 2,3-Dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective .alpha.1-adrenoceptor antagonists and antihypertensive agents